by jurvetson
Celebrity genomics without the Y chromosome: Glenn Close has her genome sequenced
[Via Genetic Future]
Zoe McDougall from Oxford Nanopore points me to a press release from Illumina announcing a new era of celebrity genomics:
Illumina, Inc. (NASDAQ:ILMN) today announced that it has sequenced the DNA of American actress Glenn Close, the first publicly named female to have her DNA sequenced to full coverage. The service was completed in Illumina’s CLIA certified and CAP accredited laboratory utilizing Illumina’s Genome Analyzer technology and following the established process shown at http://www.everygenome.com/. Ms. Close’s DNA was sequenced to an average depth greater than 30 fold, providing information on SNP variation and allowing for the analysis of other structural characteristics of the genome such as insertions, deletions and rearrangements. Specifically, over 95% of the known genome was reported, including over 12 million genotype calls on previously documented SNPs. In addition, 379,000 SNPs previously not reported in any public database were found.
While there’s nothing new about celebrity genomics, previous examples have largely been “scientific celebrities” (such as Jim Watson and Craig Venter) – so Close is the first genome with broader celebrity status, and also the first named individual without a Y chromosome to rack up her 6 billion base pairs. That’s of negligible interest scientifically, but there’s no doubt this will dramatically increase the public profile of whole genome sequencing.
(Added in edit: I’ve just been reminded by Misha Angrist that technically Close isn’t the first named female to be sequenced – a press release back in May 2008 announced the sequencing of Dutch geneticist Marjolein Kriek, although we’re yet to see an actual publication of those data and the quality of the sequence is unclear.)[More]
One worry I have with commercial DNA sequencing companies – how do I really know that the DNA sequence they give me is really mine? At this point, a company gets several 10s of thousands of dollars ($48,000 currently) and hands me a sequence.
What sort of validation is present to make sure that they really performed what they say they perform (30-fold depth, etc.)? How can I be certain they do not just make up some sequence and give it to me? How can I be certain the sequence is really mine?
I looked around on Illumina’s site some and could not find anything about the validation of its protocols, what it does to maintain the trust of its customers that it is actually providing what it says it does, or just what its quality control process is?
Now, Illumina is unlikely to be doing anything fraudulent here. It is simply not going to benefit them at all. But I wonder about what happens as the price drops and other companies entire the field. What happens when they appear on infomercials? How can we make sure they are all ethical and dot the actual sequencing?
I am sure this will be all regulated and validated but even that could fail. Look at the forensic labs that were doing work that determined a person’s guilt or innocence yet failed miserably at actually providing the correct data.
Perhaps when each of us has our own sequence, we can get together as families and compare each other’s genome. Comparison will inform us whether the sequences follow Mendelian inheritance or not.
This is not something that is going to slow things down. I just worry what happens when someone selling nutriceuticals right now decides to offer their own sequencing program. What is the process for validatation?

